Toxicological Sciences 70, 13-19 (2002)
Copyright © 2002 by the Society of Toxicology
BIOTRANSFORMATION AND TOXICOKINETICS |
Purine Nucleoside Phosphorylase as a Cytosolic Arsenate Reductase
Department of Pharmacology and Pharmacotherapy, University of Pécs, Medical School, Szigeti út 12, H-7624, Pécs, Hungary
The findings of the accompanying paper (Németi and Gregus, Toxicol. Sci. 70, 4–12) indicate that the arsenate (AsV) reductase activity of rat liver cytosol is due to an SH enzyme that uses phosphate (or its analogue, arsenate, AsV) and a purine nucleoside (guanosine or inosine) as substrates. Purine nucleoside phosphorylase (PNP) is such an enzyme. It catalyzes the phosphorolytic cleavage of 6-oxopurine nucleosides according to the following scheme: guanosine (or inosine) + phosphate 
guanine (or hypoxanthine) + ribose-1-phosphate. Therefore, we have tested the hypothesis that PNP is responsible for the thiol- and purine nucleoside-dependent reduction of AsV to AsIII by rat liver cytosol. AsIII formed from AsV was quantified by HPLC-hydride generation–atomic fluorescence spectrometry analysis of the deproteinized incubates. The following findings support the conclusion that PNP reduces AsV to AsIII, using AsV instead of phosphate in the reaction above: (1) Specific PNP inhibitors (CI-1000, BCX-1777) at a concentration of 1 µM completely inhibited cytosolic AsV reductase activity. (2) During anion-exchange chromatography of cytosolic proteins, PNP activity perfectly coeluted with the AsV reductase activity, suggesting that both activities belong to the same protein. (3) PNP purified from calf spleen catalyzed reduction of AsV to AsIII in the presence of dithiothreitol (DTT) and a 6-oxopurine nucleoside (guanosine or inosine). (4) AsV reductase activity of purified PNP, like the cytosolic AsV reductase activity, was inhibited by phosphate (a substrate of PNP alternative to AsV), guanine and hypoxanthine (products of PNP favoring the reverse reaction), mercurial thiol reagents (nonspecific inhibitors of PNP), as well as CI-1000 and BCX-1777 (specific PNP inhibitors). Thus, PNP appears to be responsible for the AsV reductase activity of rat liver cytosol in the presence of DTT. Further research should clarify the mechanism and the in vivo significance of PNP-catalyzed reduction of AsV to AsIII.
Key Words: arsenate; arsenite; purine nucleoside phosphorylase; reduction; thiols.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Nemeti and Z. Gregus Mechanism of Thiol-Supported Arsenate Reduction Mediated by Phosphorolytic-Arsenolytic Enzymes: I. The Role of Arsenolysis Toxicol. Sci., August 1, 2009; 110(2): 270 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Gregus, G. Roos, P. Geerlings, and B. Nemeti Mechanism of Thiol-Supported Arsenate Reduction Mediated by Phosphorolytic-Arsenolytic Enzymes: II. Enzymatic Formation of Arsenylated Products Susceptible for Reduction to Arsenite by Thiols Toxicol. Sci., August 1, 2009; 110(2): 282 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu and M. P. Waalkes Liver is a Target of Arsenic Carcinogenesis Toxicol. Sci., September 1, 2008; 105(1): 24 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nemeti and Z. Gregus Glutathione-Dependent Reduction of Arsenate by Glycogen Phosphorylase A Reaction Coupled to Glycogenolysis Toxicol. Sci., November 1, 2007; 100(1): 36 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Gregus and B. Nemeti Glutathione-Dependent Reduction of Arsenate by Glycogen Phosphorylase Responsiveness to Endogenous and Xenobiotic Inhibitors Toxicol. Sci., November 1, 2007; 100(1): 44 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nemeti, I. Csanaky, and Z. Gregus Effect of an Inactivator of Glyceraldehyde-3-Phosphate Dehydrogenase, a Fortuitous Arsenate Reductase, on Disposition of Arsenate in Rats Toxicol. Sci., March 1, 2006; 90(1): 49 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Gregus and B. Nemeti The Glycolytic Enzyme Glyceraldehyde-3-Phosphate Dehydrogenase Works as an Arsenate Reductase in Human Red Blood Cells and Rat Liver Cytosol Toxicol. Sci., June 1, 2005; 85(2): 859 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nemeti and Z. Gregus Reduction of Arsenate to Arsenite by Human Erythrocyte Lysate and Rat Liver Cytosol - Characterization of a Glutathione- and NAD-Dependent Arsenate Reduction Linked to Glycolysis Toxicol. Sci., June 1, 2005; 85(2): 847 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Kenyon, L. M. Del Razo, and M. F. Hughes Tissue Distribution and Urinary Excretion of Inorganic Arsenic and Its Methylated Metabolites in Mice Following Acute Oral Administration of Arsenate Toxicol. Sci., May 1, 2005; 85(1): 468 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nemeti and Z. Gregus Glutathione-Dependent Reduction of Arsenate in Human Erythrocytes--a Process Independent of Purine Nucleoside Phosphorylase Toxicol. Sci., December 1, 2004; 82(2): 419 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-W. Ting, M.-F. Wu, C.-T. Tsai, C.-C. Lin, I.-C. Guo, and C.-Y. Chang Identification and characterization of a novel gene of grouper iridovirus encoding a purine nucleoside phosphorylase J. Gen. Virol., October 1, 2004; 85(10): 2883 - 2892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Leslie, A. Haimeur, and M. P. Waalkes Arsenic Transport by the Human Multidrug Resistance Protein 1 (MRP1/ABCC1): EVIDENCE THAT A TRI-GLUTATHIONE CONJUGATE IS REQUIRED J. Biol. Chem., July 30, 2004; 279(31): 32700 - 32708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nemeti, I. Csanaky, and Z. Gregus Arsenate Reduction in Human Erythrocytes and Rats--Testing the Role of Purine Nucleoside Phosphorylase Toxicol. Sci., July 1, 2003; 74(1): 22 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nemeti and Z. Gregus Reduction of Arsenate to Arsenite in Hepatic Cytosol Toxicol. Sci., November 1, 2002; 70(1): 4 - 12. [Abstract] [Full Text] [PDF]
|
|